721001 Research and experimental development in the pharmaceutical industry
A six-digit type of NOGA 2025, in division 72, Scientific research and development.
Where it sits
- Section
- N Professional, Scientific and Technical Activities
- Division
- 72 Scientific research and development
- Group
- 721 Research and experimental development on natural sciences and engineering
- Class
- 7210 Research and experimental development on natural sciences and engineering
- Type
- 721001 Research and experimental development in the pharmaceutical industry
Its name in four languages
- Deutsch
- Forschung und Entwicklung in der pharmazeutischen Industrie
- Français
- Recherche et développement dans l'industrie pharmaceutique
- Italiano
- Ricerca e sviluppo nell'industria farmaceutica
- English
- Research and experimental development in the pharmaceutical industry
What it includes
- research and experimental development in the pharmaceutical industry:
- research and development on medical, health and life, and veterinary sciences
- research and development on biotechnology
It also includes
- DNA sequencing for general research on biological processes
What it excludes
- DNA sequencing for ruling out or curing a specific disease, see 869102
NOGA 2008 codes it continues
Since the switch to NOGA 2025, companies coded under these NOGA 2008 types belong under 721001, in the share the BFS measured in its business register (BUR).
| NOGA 2008 | Share moved to 721001 |
|---|---|
| 721100 | 100% |
| 721900 | 29% |
Other codes in the same group
What a NOGA code is, and how to find a company's code
Company counts cover the 145,068 of 782,904 active companies in the commercial register that Prospex has coded so far, from their registered purpose and website, so they are a floor. Geneva is 93% coded, because its cantonal register publishes a code per company; the other cantons 11% so far. They are Prospex's codes, not the code the BFS assigns in its business register (BUR). Codes, labels and notes: Swiss Federal Statistical Office (BFS), NOGA 2025, through the I14Y interoperability platform and the KUBB coding tool.